NO324215B1 - Anvendelse av levobupivakain for fremstilling av et medikament - Google Patents

Anvendelse av levobupivakain for fremstilling av et medikament Download PDF

Info

Publication number
NO324215B1
NO324215B1 NO19994259A NO994259A NO324215B1 NO 324215 B1 NO324215 B1 NO 324215B1 NO 19994259 A NO19994259 A NO 19994259A NO 994259 A NO994259 A NO 994259A NO 324215 B1 NO324215 B1 NO 324215B1
Authority
NO
Norway
Prior art keywords
levobupivacaine
bupivacaine
doses
drug
absence
Prior art date
Application number
NO19994259A
Other languages
English (en)
Norwegian (no)
Other versions
NO994259L (no
NO994259D0 (no
Inventor
Brian Albert Gennery
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO994259D0 publication Critical patent/NO994259D0/no
Publication of NO994259L publication Critical patent/NO994259L/no
Publication of NO324215B1 publication Critical patent/NO324215B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO19994259A 1997-03-03 1999-09-02 Anvendelse av levobupivakain for fremstilling av et medikament NO324215B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704351.7A GB9704351D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000664 WO1998038999A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in paediatric surgery

Publications (3)

Publication Number Publication Date
NO994259D0 NO994259D0 (no) 1999-09-02
NO994259L NO994259L (no) 1999-11-02
NO324215B1 true NO324215B1 (no) 2007-09-10

Family

ID=10808602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994259A NO324215B1 (no) 1997-03-03 1999-09-02 Anvendelse av levobupivakain for fremstilling av et medikament

Country Status (20)

Country Link
US (1) US5910502A (cg-RX-API-DMAC10.html)
EP (1) EP0981348B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001513814A (cg-RX-API-DMAC10.html)
KR (1) KR100535554B1 (cg-RX-API-DMAC10.html)
CN (1) CN1107504C (cg-RX-API-DMAC10.html)
AT (1) ATE240731T1 (cg-RX-API-DMAC10.html)
AU (1) AU719483B2 (cg-RX-API-DMAC10.html)
BR (1) BR9808302A (cg-RX-API-DMAC10.html)
CA (1) CA2279498C (cg-RX-API-DMAC10.html)
DE (1) DE69814852T2 (cg-RX-API-DMAC10.html)
DK (1) DK0981348T3 (cg-RX-API-DMAC10.html)
ES (1) ES2199424T3 (cg-RX-API-DMAC10.html)
GB (1) GB9704351D0 (cg-RX-API-DMAC10.html)
HU (1) HU224227B1 (cg-RX-API-DMAC10.html)
IL (1) IL131086A0 (cg-RX-API-DMAC10.html)
NO (1) NO324215B1 (cg-RX-API-DMAC10.html)
PL (1) PL190896B1 (cg-RX-API-DMAC10.html)
PT (1) PT981348E (cg-RX-API-DMAC10.html)
WO (1) WO1998038999A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA981780B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
ATE507816T1 (de) * 2001-11-14 2011-05-15 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004012703A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
CN1684663A (zh) * 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
HK1022649A1 (en) 2000-08-18
HUP0000963A3 (en) 2000-10-30
ES2199424T3 (es) 2004-02-16
BR9808302A (pt) 2000-05-16
DK0981348T3 (da) 2003-09-15
HUP0000963A2 (hu) 2000-09-28
HU224227B1 (hu) 2005-06-28
NO994259L (no) 1999-11-02
DE69814852D1 (de) 2003-06-26
ATE240731T1 (de) 2003-06-15
ZA981780B (en) 1999-03-03
KR100535554B1 (ko) 2005-12-08
AU719483B2 (en) 2000-05-11
PT981348E (pt) 2003-09-30
CA2279498C (en) 2009-05-26
IL131086A0 (en) 2001-01-28
US5910502A (en) 1999-06-08
PL190896B1 (pl) 2006-02-28
CN1107504C (zh) 2003-05-07
EP0981348B1 (en) 2003-05-21
GB9704351D0 (en) 1997-04-23
PL335563A1 (en) 2000-05-08
JP2001513814A (ja) 2001-09-04
CA2279498A1 (en) 1998-09-11
WO1998038999A1 (en) 1998-09-11
KR20000075894A (ko) 2000-12-26
DE69814852T2 (de) 2004-01-22
NO994259D0 (no) 1999-09-02
AU6631098A (en) 1998-09-22
EP0981348A1 (en) 2000-03-01
CN1249683A (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
EP0981348B1 (en) The use of levobupivacaine in paediatric surgery
Phillips-Howard et al. The safety of antimalarial drugs in pregnancy
Van den Berg et al. The oculo‐emetic reflex: A rationalisation of postophthalmic anaesthesia vomiting
US5849763A (en) Use of levobupivacaine as an anesthetic agent
Murdoch Peribulbar versus retrobulbar anaesthesia
KR100516676B1 (ko) 안면 수술에서의 레보부피바카인의 용도
Boezaart et al. A comparison of propofol and remifentanil for sedation and limitation of movement during periretrobulbar block
Kallio et al. Topical anesthesia with or without propofol sedation versus retrobulbar/peribulbar anesthesia for cataract extraction: prospective randomized trial
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
Logan et al. SINGLE-SHOT IV ANAESTHESIA FOR OUTPATIENT DENTAL SURGERY: Comparison of 2, 6 Di-isopropyl Phenol and Methohexitone
US20040192699A1 (en) Optic nerve protecting agents containing alpha1 receptor blocker as active ingredient
SK280111B6 (sk) Použitie ropivakaínu na výrobu farmaceutického pro
Watson et al. Effect of nebulized ipratropium bromide on intraocular pressures in children
EP3701956B1 (en) Prophylactic and/or therapeutic agent for dementia
Harris et al. The use of CI-581, a new parenteral anesthetic, in ophthalmic practice
HK1022649B (en) The use of levobupivacaine in paediatric surgery
Kovac et al. Effect of esmolol on hemodynamics and intraocular pressure response to succinylcholine and intubation following low-dose alfentanil premedication
MXPA99008057A (en) The use of levobupivacaine in paediatric surgery
Fan et al. The use of peribulbar anaesthesia in paediatric cataract surgery (age 7–15 years) in a mobile eye camp in China
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
Salem et al. The effects of atropine and glycopyrrolate on intra‐ocular pressure in anasthetised elderly patients
Fathi et al. Carticaine versus lidocaine for peribulbar anesthesia in cataract surgery
Norman et al. Association of high-dose intravenous methylprednisolone with reversal of blindness from lightning in two patients
Kinross-Wright Succinylcholine in electroshock treatment
Dornette et al. Clinical and laboratory experience with ethyl vinyl ether.

Legal Events

Date Code Title Description
MK1K Patent expired